Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Medroxyprogesterone
Drug ID BADD_D01365
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code G03AC06; G03DA02; L02AB02
DrugBank ID Not Available
KEGG ID D08166
MeSH ID D008525
PubChem ID 10631
TTD Drug ID D0I2SD
NDC Product Code 54348-805; 0009-0067
UNII HSU1C9YRES
Synonyms Medroxyprogesterone | (6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione | Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)- | 17 alpha-Hydroxy-6 alpha-Methylprogesterone | 17 alpha Hydroxy 6 alpha Methylprogesterone | Methylhydroxyprogesterone | Adgyn Medro
Chemical Information
Molecular Formula C22H32O3
CAS Registry Number 520-85-4
SMILES CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Fatigue08.01.01.002--
Fibrocystic breast disease21.05.04.018; 16.14.01.003--Not Available
Flatulence07.01.04.002--
Fluid retention14.05.06.002; 20.01.02.003--Not Available
Galactorrhoea21.05.02.002; 05.03.04.002--Not Available
Gallbladder disorder09.03.02.001--Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Glucose tolerance decreased13.02.02.004--Not Available
Haemangioma16.02.01.002; 24.03.06.004--Not Available
Haemoglobin13.01.05.018--Not Available
Headache17.14.01.001--
Hirsutism23.02.04.001; 05.05.01.005--
Hypercalcaemia14.04.01.003; 05.04.01.002--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperplasia08.03.04.008--Not Available
Hypersensitivity10.01.03.003--
Hypocalcaemia14.04.01.004--
Immune system disorder10.02.01.001--Not Available
Infection11.01.08.002--Not Available
Influenza22.07.02.001; 11.05.03.001--Not Available
Injection site pain12.07.03.011; 08.02.03.010--Not Available
Injection site reaction12.07.03.015; 08.02.03.014--
Insomnia19.02.01.002; 17.15.03.002--
Irritability08.01.03.011; 19.04.02.013--
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
Jaundice cholestatic09.01.01.005--Not Available
Jaundice neonatal18.04.08.001; 09.01.01.008; 01.06.04.006--Not Available
Libido decreased21.03.02.005; 19.08.03.001--
Libido increased21.03.02.007; 19.08.03.002--
The 3th Page    First    Pre   3 4 5 6    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene